By Associate Professor Miriam Tania Levy

Journal articles

Wigg A; Tibballs J; Woodman R; Stuart K; Le H; Roberts SK; Olynyk JK; Strasser SI; Wallace M; Martin J; Haworth A; Hardcastle N; Loo KF; Tang C; Lee YY; Chu J; De Abreu Lourenco R; Koukourou A; De Boo D; McLean K; Buck J; Sawhney R; Nicoll A; Dev A; Wood M; Braund A; Weltman M; Khor R; Levy M; Wang T; Potter M; Haridy J; Raj A; Duncan O; Zekry A; Collier N; O’Beirne J; Holliday C; Trada Y; Tronidjaja J; George J; Pryor D, 2024, 'A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)', BMC Cancer, 24, http://dx.doi.org/10.1186/s12885-024-12504-2

Gofton C; Di Bartolomeo A; Boutros R; Zurynski YA; Stafford-Bell F; Caldwell K; McCaughan G; Zekry A; Strasser SI; Levy M; Sheehan C; Goodall S; Davis JM; Sheahan L; Liu K; Greenaway S; Davison S; Du Huynh T; Quadri Z; Agar M; George J, 2024, 'Implementing palliative care in hepatocellular carcinoma ambulatory clinics—study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08603-x

Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ, 2024, 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy', Liver International, 44, pp. 2605 - 2614, http://dx.doi.org/10.1111/liv.16029

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK, 2024, 'Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)', Drug and Alcohol Review, 43, pp. 1559 - 1572, http://dx.doi.org/10.1111/dar.13914

Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2024, 'Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia', Internal Medicine Journal, 54, pp. 602 - 612, http://dx.doi.org/10.1111/imj.16252

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Bollipo S; McGarity B; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK, 2024, 'Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care', Journal of Gastroenterology and Hepatology (Australia), 39, pp. 568 - 575, http://dx.doi.org/10.1111/jgh.16440

McNamara J; Joseph R; Stratton E; Levy MT; Prakoso E, 2024, 'Evolving Trends in Hepatocellular Carcinoma in a Multi-Cultural Australian Tertiary Centre', Journal of Gastrointestinal Cancer, 55, pp. 188 - 189, http://dx.doi.org/10.1007/s12029-023-00995-4

Waller KMJ; Prince DS; Lai EHY; Levy MT; Strasser SI; McCaughan GW; Teng MLP; Huang DQ; Liu K, 2024, 'The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort study', ESMO Gastrointestinal Oncology, 3, pp. 100043 - 100043, http://dx.doi.org/10.1016/j.esmogo.2024.100043

Girolamo JD; Prince D; Alshiwanna B; Porritt R; Thomas D; Bakridi S; Tran H; Gryllis S; Tiglao M; Haack R; Peralta K; Bagatella M; Petrovski I; Doan J; Cracknell R; Lawrence J; Maley M; Foo H; Jones N; Dore G; Levy M, 2024, 'WED-422 Screening for viral hepatitis in the emergency department-the methodology to automate a feasible, acceptable and effective solution', Journal of Hepatology, 80, pp. S657 - S657, http://dx.doi.org/10.1016/s0168-8278(24)01891-9

Alshiwanna B; Levy M; Girolamo JD; Bagatella M; Petrovski I; Porritt R; Thomas D; Bakridi S; Tran H; Gryllis S; Tiglao M; Haack R; Peralta K; Doan J; Lawrence J; Cracknell R; Maley M; Foo H; Jones N; Dore G; Prince D, 2024, 'WED-470 Screening emergency admissions at risk of chronic hepatitis 3 extension (SEARCH 3X)-universal is better than risk-based screening for viral hepatitis', Journal of Hepatology, 80, pp. S676 - S676, http://dx.doi.org/10.1016/s0168-8278(24)01936-6

Thompson AJ; Jackson K; Bonanzinga S; Hall SAL; Hume S; Burns GS; Sundararajan V; Ratnam D; Levy MT; Lubel J; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden DS; Canchola JA; Torres J; Siew P; Lau J; Brot BL; Kuchta A; Visvanathan K, 2023, 'Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000188

Guliyara MA; Ermerak G; Levy M; Koo JH; Bassan M, 2023, 'Frailty predicts mortality in patients with upper gastrointestinal bleed: a prospective cohort study', Journal of Gastroenterology and Hepatology (Australia), 38, pp. 1292 - 1298, http://dx.doi.org/10.1111/jgh.16188

Foo H; Phan F; Bagatella M; Petrovski I; Nagendra V; Acharya P; Levy M; Prakoso E, 2023, 'Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19', European Journal of Clinical Microbiology and Infectious Diseases, 42, pp. 799 - 801, http://dx.doi.org/10.1007/s10096-023-04599-5

Hall SAL; Burns GS; Mooney BJ; Millen R; Morris R; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden S; Locarnini SA; Thompson AJ; Visvanathan K, 2023, 'Hepatitis B Virus Flares after Nucleot(s)ide Analogue Cessation Are Associated with Activation of Toll-Like Receptor Signaling Pathways', Journal of Infectious Diseases, 227, pp. 123 - 132, http://dx.doi.org/10.1093/infdis/jiac375

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2023, 'Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort', Digestive Diseases and Sciences, 68, pp. 291 - 303, http://dx.doi.org/10.1007/s10620-022-07483-y

Thilakanathan C; Kayes T; Di Girolamo J; Nguyen V; Glass A; Manandhar S; Lawler J; Meredith C; Maley M; Lloyd A; Levy MT, 2023, 'Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore', Liver International, 43, pp. 69 - 76, http://dx.doi.org/10.1111/liv.15372

Jacob R; Prince DS; Pipicella JL; Nguyen A; Bagatella M; Alvaro F; Maley M; Foo H; Middleton P; Kayes T; DiGirolamo J; Davison S; Levy MT, 2023, 'Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care', Liver International, 43, pp. 60 - 68, http://dx.doi.org/10.1111/liv.15414

Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up', BMC Gastroenterology, 22, http://dx.doi.org/10.1186/s12876-022-02416-5

Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK, 2022, 'Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus', Hepatology Communications, 6, pp. 3260 - 3271, http://dx.doi.org/10.1002/hep4.2089

Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K, 2022, 'Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study', Journal of Gastroenterology and Hepatology (Australia), 37, pp. 2173 - 2181, http://dx.doi.org/10.1111/jgh.15986

Prince DS; Girolamo JD; Pipicella JL; Bagatella M; Kayes T; Alvaro F; Maley M; Foo H; Middleton PM; Levy MT, 2022, 'Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?', Canadian Journal of Gastroenterology and Hepatology, 2022, pp. 1 - 9, http://dx.doi.org/10.1155/2022/3449938

Patwala K; Prince DS; Celermajer Y; Alam W; Paul E; Strasser SI; McCaughan GW; Gow P; Sood S; Murphy E; Roberts S; Freeman E; Stratton E; Davison SA; Levy MT; Clark-Dickson MC; Nguyen V; Bell S; Nicoll A; Bloom A; Lee AU; Ryan M; Howell J; Valaydon Z; Mack A; Liu K; Dev A, 2022, 'Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study', Hepatology International, 16, pp. 1170 - 1178, http://dx.doi.org/10.1007/s12072-022-10398-5

Kayes T; Crane H; Symonds A; Dumond J; Cottrell M; Di Girolamo J; Manandhar S; Lim TH; Gane E; Kashuba A; Levy MT, 2022, 'Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection', Alimentary Pharmacology and Therapeutics, 56, pp. 510 - 518, http://dx.doi.org/10.1111/apt.17040

Levy MT; Kashuba A; Gane E, 2022, 'Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection—Authors' reply', Alimentary Pharmacology and Therapeutics, 56, pp. 548 - 549, http://dx.doi.org/10.1111/apt.17102

Hall SAL; Burns GS; Anagnostou D; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll A; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden D; Locarnini SA; Visvanathan K; Thompson A, 2022, 'Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels', Alimentary Pharmacology and Therapeutics, 56, pp. 310 - 320, http://dx.doi.org/10.1111/apt.16968

Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy', Journal of Gastroenterology and Hepatology (Australia), 36, pp. 3515 - 3523, http://dx.doi.org/10.1111/jgh.15687

Papaluca T; Roberts SK; Strasser SI; Stuart KA; Farrell G; Macquillan G; Dore GJ; Wade AJ; George J; Hazeldine S; O'Beirne J; Wigg A; Fisher L; McGarity B; Sawhney R; Sinclair M; Thomas J; Valiozis I; Weltman M; Wilson M; Woodward A; Ahlenstiel G; Haque M; Levy M; Prewett E; Sievert W; Sood S; Tse E; Valaydon Z; Bowden S; Douglas M; New K; O'Keefe J; Hellard M; Doyle J; Stoove M; Thompson AJ, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, 73, pp. E3288 - E3295, http://dx.doi.org/10.1093/cid/ciaa1318

Dore G; Levy M, 2021, 'Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1318

O'Brien ER; Whelan MC; Lama T; Levy M, 2021, 'Public health unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP30342010

Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DHG; Levy MT; Shackel N, 2021, 'Australian recommendations for the management of hepatocellular carcinoma: a consensus statement', Medical Journal of Australia, 214, pp. 475 - 483, http://dx.doi.org/10.5694/mja2.50885

Terrault NA; Cheung KW; Levy MT; Jourdain G, 2021, 'Reply to ‘Evidence against in utero transmission of hepatitis B virus’', Nature Reviews Gastroenterology and Hepatology, 18, pp. 445 - 446, http://dx.doi.org/10.1038/s41575-021-00456-y

Lockart I; Hajarizadeh B; Alavi M; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival', Journal of Viral Hepatitis, 28, pp. 710 - 718, http://dx.doi.org/10.1111/jvh.13475

Levy MT; Terrault NA, 2021, 'Caesarean section or non-breastfeeding for prevention of MTCT—beware of sending the wrong message', Journal of Viral Hepatitis, 28, pp. 575 - 576, http://dx.doi.org/10.1111/jvh.13455

Terrault NA; Levy MT; Cheung KW; Jourdain G, 2021, 'Viral hepatitis and pregnancy', Nature Reviews Gastroenterology and Hepatology, 18, pp. 117 - 130, http://dx.doi.org/10.1038/s41575-020-00361-w

Prince DS; Pipicella JL; Fraser M; Alvaro F; Maley M; Foo H; Middleton PMC; Davison SA; Dore GJ; McCaughan GW; Levy MT, 2021, 'Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or ‘re-diagnose’ infections is effective in Australia', Journal of Viral Hepatitis, 28, pp. 121 - 128, http://dx.doi.org/10.1111/jvh.13393

Razavi H; Blach S; Razavi-Shearer D; Abaalkhail F; Abbas Z; Abdallah A; Abrao Ferreira P; Abu Raddad LJ; Adda D; Agarwal K; Aghemo A; Ahmed A; Al-Busafi SA; Al-hamoudi W; Al-Kaabi S; Al-Romaihi H; Aljarallah B; AlNaamani K; Alqahtani S; Alswat K; Altraif I; Asselah T; Bacon B; Bessone F; Bizri AR; Block T; Bonino F; Brandão-Mello CE; Brown K; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Calleja JL; Castro Batänjer E; Chan HLY; Chang H; Chen CJ; Christensen PB; Chuang WL; Cisneros L; Cohen C; Colombo M; Conway B; Cooper C; Craxi A; Crespo J; Croes E; Cryer D; Cupertino de Barros FP; Derbala M; Dillon J; Doss W; Dou X; Doyle J; Duberg AS; Dugan E; Dunn R; Dusheiko G; El Khayat H; El-Sayed MH; Eshraghian A; Esmat G; Esteban Mur R; Ezzat S; Falconer K; Fassio E; Ferrinho P; Flamm S; Flisiak R; Foster G; Fung J; García-Samaniego J; Gish RG; Gonçales F; Halota W; Hamoudi W; Hassany M; Hatzakis A; Hay S; Himatt S; Hoepelman IM; Hsu YC; Hui YT; Hunyady B; Jacobson I; Janjua N; Janssen H; Jarcuska P; Kabagambe K; Kanto T; Kao JH; Kaymakoglu S; Kershenobich D; Khamis F; Kim DJ; Kim DY; Kondili LA; Kottilil S; Kramvis A, 2021, 'The case for simplifying and using absolute targets for viral hepatitis elimination goals', Journal of Viral Hepatitis, 28, pp. 12 - 19, http://dx.doi.org/10.1111/jvh.13412

Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E, 2020, 'Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia', Hepatobiliary and Pancreatic Diseases International, 19, pp. 541 - 546, http://dx.doi.org/10.1016/j.hbpd.2020.06.013

Crane HG; Davison SA; Levy MT, 2020, 'Editorial: the emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C', Alimentary Pharmacology and Therapeutics, 51, pp. 168 - 169, http://dx.doi.org/10.1111/apt.15525

Hall S; Burns G; Levy M; Lubel J; Nicoll A; Matthews G; Desmond P; Sievert W; Bowden S; Locarnini S; Holmes J; Visvanathan K; Thompson A, 2020, 'A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare', Journal of Hepatology, 73, pp. S69 - S70, http://dx.doi.org/10.1016/s0168-8278(20)30674-7

Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248

Mohsen W; Chan P; Whelan M; Glass A; Mouton M; Young E; Tran Q; Arora S; Davison S; Lama T; Cobrador C; Levy M, 2019, 'Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?', Internal Medicine Journal, 49, pp. 351 - 357, http://dx.doi.org/10.1111/imj.14072

Lockart I; Das A; Merrett N; Levy M, 2018, 'Migration route of Fasciola into the liver', JGH open, 3, pp. 89 - 90, http://dx.doi.org/10.1002/jgh3.12101

Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT, 2018, 'Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing', Liver International, 38, pp. 1212 - 1219, http://dx.doi.org/10.1111/liv.13736

Levy MT; Mohsen W, 2018, 'Author reply', Internal Medicine Journal, 48, pp. 486, http://dx.doi.org/10.1111/imj.13747

Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063

Ermerak GG; Behary J; Tran G; Koo K; Levy MT; Bassan MS, 2018, 'Mo1198 - Frailty and Aims65 Score Predict Mortality in Hospitalized Patients with Gastrointestinal Bleeding: A Prospective Cohort Study', Gastroenterology, 154, http://dx.doi.org/10.1016/s0016-5085(18)32479-x

Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x

Wang XM; Holz LE; Chowdhury S; Cordoba SP; Evans KA; Gall MG; De Ribeiro AJV; Zheng YZ; Levy MT; Yu DMT; Yao TW; Polak N; Jolly CJ; Bertolino P; McCaughan GW; Gorrell MD, 2017, 'The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury', Immunology and Cell Biology, 95, pp. 443 - 453, http://dx.doi.org/10.1038/icb.2016.116

Mohsen W; Levy MT, 2017, 'Hepatitis A to E: what's new?', Internal Medicine Journal, 47, pp. 380 - 389, http://dx.doi.org/10.1111/imj.13386

Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168

Back to profile page